Clarus Therapeutics Holdings Net Tangible Assets

Clarus Therapeutics Holdings (CRXT) currently reports a net tangible assets of $-13M as of June 2022. That compares with $-350M in the prior-year period — up 96.3% year over year. Use the charts on this page to explore Clarus Therapeutics Holdings's net tangible assets history and peer comparisons.

Clarus Therapeutics Holdings's net tangible assets increased from $-350M to $-13M — a 96.3% year-over-year increase (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clarus Therapeutics Holdings reported $-13M in net tangible assets as of June 2022. That compares with $-350M in the prior-year period — up 96.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clarus Therapeutics Holdings, and consider following CRXT for alerts when major investors trade the stock.